Life Sciences 2026

POLAND Law and Practice Contributed by: Marcin Tomasik, Tomasz Jaworski, Filip Gołba and Jakub Matusiak, Tomasik Jaworski Sp.p.

pharmacy technicians) should inform a patient about the availability of an affordable and publicly reim- bursed equivalent whose retail price does not exceed the price of the prescribed product and the financing limit. In the case of medicines, the equivalent has to share its international name, dosage and indication with the prescribed product, and must have a phar- maceutical form that cannot give rise to therapeutic differences. The pharmacy is obliged to display this information on its premises.

Pharmacy staff are also obliged to issue an equiva- lent to patients who make such requests. Upon the patient’s request, the pharmacy may also dispense another reimbursed equivalent even if its retail price is equal to or higher than the prescribed reimbursed product (subject to statutory conditions). Dispensing a non-reimbursed equivalent is possible upon the patient’s request, but it is not part of the mandatory cheaper reimbursed equivalent substitution duty and is paid by the patient in full. These rules also apply to pharmacy outlets.

249 CHAMBERS.COM

Powered by